Skip to main content

Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.

Publication ,  Journal Article
Portale, AA; Wolf, MS; Messinger, S; Perwad, F; Jüppner, H; Warady, BA; Furth, SL; Salusky, IB
Published in: Clin J Am Soc Nephrol
November 7, 2016

BACKGROUND AND OBJECTIVES: Plasma fibroblast growth factor 23 (FGF23) concentrations increase early in the course of CKD in children. High FGF23 levels associate with progression of CKD in adults. Whether FGF23 predicts CKD progression in children is unknown. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We tested the hypothesis that high plasma FGF23 is an independent risk factor for CKD progression in 419 children, aged 1-16 years, enrolled in the Chronic Kidney Disease in Children (CKiD) cohort study. We measured plasma FGF23 concentrations at baseline and determined GFR annually using plasma disappearance of iohexol or the CKiD study estimating equation. We analyzed the association of baseline FGF23 with risk of progression to the composite end point, defined as start of dialysis or kidney transplantation or 50% decline from baseline GFR, adjusted for demographics, baseline GFR, proteinuria, other CKD-specific factors, and other mineral metabolites. RESULTS: At enrollment, median age was 11 years [interquartile range (IQR), 8-15], GFR was 44 ml/min per 1.73 m2 (IQR, 33-57), and FGF23 was 132 RU/ml (IQR, 88-200). During a median follow-up of 5.5 years (IQR, 3.5-6.6), 32.5% of children reached the progression end point. Higher FGF23 concentrations were independently associated with higher risk of the composite outcome (fully adjusted hazard ratio, 2.52 in the highest versus lowest FGF23 tertile; 95% confidence interval, 1.44 to 4.39, P=0.002; fully adjusted hazard ratio, 1.33 per doubling of FGF23; 95% confidence interval, 1.13 to 1.56, P=0.001). The time to progression was 40% shorter for participants in the highest compared with the lowest FGF23 tertile. In contrast, serum phosphorus, vitamin D metabolites, and parathyroid hormone did not consistently associate with progression in adjusted analyses. CONCLUSIONS: High plasma FGF23 is an independent risk factor for CKD progression in children.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clin J Am Soc Nephrol

DOI

EISSN

1555-905X

Publication Date

November 7, 2016

Volume

11

Issue

11

Start / End Page

1989 / 1998

Location

United States

Related Subject Headings

  • Vitamin D
  • Urology & Nephrology
  • Risk Factors
  • Risk Assessment
  • Renal Insufficiency, Chronic
  • Renal Dialysis
  • Prospective Studies
  • Phosphorus
  • Parathyroid Hormone
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Portale, A. A., Wolf, M. S., Messinger, S., Perwad, F., Jüppner, H., Warady, B. A., … Salusky, I. B. (2016). Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. Clin J Am Soc Nephrol, 11(11), 1989–1998. https://doi.org/10.2215/CJN.02110216
Portale, Anthony A., Myles S. Wolf, Shari Messinger, Farzana Perwad, Harald Jüppner, Bradley A. Warady, Susan L. Furth, and Isidro B. Salusky. “Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.Clin J Am Soc Nephrol 11, no. 11 (November 7, 2016): 1989–98. https://doi.org/10.2215/CJN.02110216.
Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, et al. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1989–98.
Portale, Anthony A., et al. “Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.Clin J Am Soc Nephrol, vol. 11, no. 11, Nov. 2016, pp. 1989–98. Pubmed, doi:10.2215/CJN.02110216.
Portale AA, Wolf MS, Messinger S, Perwad F, Jüppner H, Warady BA, Furth SL, Salusky IB. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1989–1998.

Published In

Clin J Am Soc Nephrol

DOI

EISSN

1555-905X

Publication Date

November 7, 2016

Volume

11

Issue

11

Start / End Page

1989 / 1998

Location

United States

Related Subject Headings

  • Vitamin D
  • Urology & Nephrology
  • Risk Factors
  • Risk Assessment
  • Renal Insufficiency, Chronic
  • Renal Dialysis
  • Prospective Studies
  • Phosphorus
  • Parathyroid Hormone
  • Male